YU9101A - Tretiranje bolesti zavisnosti i ponašanja vezanog za bolesti zavisnosti - Google Patents

Tretiranje bolesti zavisnosti i ponašanja vezanog za bolesti zavisnosti

Info

Publication number
YU9101A
YU9101A YU9101A YU9101A YU9101A YU 9101 A YU9101 A YU 9101A YU 9101 A YU9101 A YU 9101A YU 9101 A YU9101 A YU 9101A YU 9101 A YU9101 A YU 9101A
Authority
YU
Yugoslavia
Prior art keywords
addiction
related behavior
treating
effective amount
mammal
Prior art date
Application number
YU9101A
Other languages
English (en)
Inventor
Stephen L. Dewey
Jonathan D. Brodie
Charles R. Ashby Jr.
Original Assignee
Brookhaven Science Associates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/129,253 external-priority patent/US6057368A/en
Priority claimed from US09/209,952 external-priority patent/US6541520B1/en
Application filed by Brookhaven Science Associates filed Critical Brookhaven Science Associates
Publication of YU9101A publication Critical patent/YU9101A/sh

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Predmetni pronalazak obezbedjuje postupak za promenu ponašanja koje je vezano sa zavisnošću sisara koji pati od zavisnosti od droga zloupotrebe. Postupak obuhvata primenu kod sisara efikasne količine gama vinilGABA (GVG) ili njene farmaceutski prihvatljive soli njenog enantiomera ili racemske smeše, gde efikasna količina je dovoljna da smanji, inhibira ili eliminiše ponašanje koje je povezano sa žudnjom ili primenom zloupotrebljavanih droga.[The present invention provides a method for changing addiction-related behavior of a mammal suffering from addiction to abused drugs. The method includes administering to the mammal an effective amount of gamma vinylGABA (GVG) or a pharmaceutically acceptable salt thereof, or an enantiomer or a racemic mixture thereof, wherein the effective amount is sufficient to diminish, ihhibit or eliminate behavior associated with craving or use of abused drugs.
YU9101A 1998-08-05 1999-08-05 Tretiranje bolesti zavisnosti i ponašanja vezanog za bolesti zavisnosti YU9101A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/129,253 US6057368A (en) 1998-08-05 1998-08-05 Treatment of addiction and addiction-related behavior
US09/189,166 US6828349B1 (en) 1998-08-05 1998-11-09 Treatment of addiction and addiction-related behavior
US09/209,952 US6541520B1 (en) 1998-08-05 1998-12-11 Treatment of addiction and addiction-related behavior

Publications (1)

Publication Number Publication Date
YU9101A true YU9101A (sh) 2003-01-31

Family

ID=47682116

Family Applications (1)

Application Number Title Priority Date Filing Date
YU9101A YU9101A (sh) 1998-08-05 1999-08-05 Tretiranje bolesti zavisnosti i ponašanja vezanog za bolesti zavisnosti

Country Status (2)

Country Link
KR (1) KR20010085332A (sh)
YU (1) YU9101A (sh)

Also Published As

Publication number Publication date
KR20010085332A (ko) 2001-09-07

Similar Documents

Publication Publication Date Title
DE69529412D1 (en) Hydromorphone-therapie
IL141067A0 (en) Treatment of addiction and addiction-related behavior
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
AU1718400A (en) Method for treating pain
ZA977783B (en) Method of inhibiting fibrosis with a somatostatin agonist
HK1017986A1 (en) Treating urinary incontinence using (s)-oxybutyninand (s)-desethyloxybutynin.
EP0935415A4 (en) METHOD FOR MAKING CONNECTIONS INTO A CELL
WO1999013862A3 (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
HK1046374A1 (en) Camptothecin analogs and methods of preparation thereof
HK1007680A1 (en) Pharmacological treatment of ocular development
NZ332215A (en) Transdermally administered dextromethorphan as antitussive agent
HK1024631A1 (en) Use of (+) mefloquine for the treatment of malaria
WO2000010554A3 (en) Methods and compositions employing optically pure s(+) vigabatrin
NZ509198A (en) Treatment for multiple sclerosis using a histamine H2 agonist in combination with a phosphodiesterase inhibitor
EP0381696A4 (en) Treatment of cocaine addiction
IL126725A0 (en) Compositions comprising a nitrone compound for use in treating ocular inflammation
YU9101A (sh) Tretiranje bolesti zavisnosti i ponašanja vezanog za bolesti zavisnosti
MXPA03010407A (es) Prevencion de adiccion en gestion del dolor.
ES8800048A1 (es) Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada.
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
MY113406A (en) Methods of inhibiting physiological conditions associated with an excess of bradykinin
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
IL126158A0 (en) Method for treating substance abuse
UA18878A (uk) Спосіб лікуваhhя алкогольhої та hаркотичhої залежhості
UA33683A (uk) Спосіб лікування поліпозного риносинуїту